Maas BiolAB Receives Innovate Albuquerque Award

ALBUQUERQUE, N.M. ---February 21, 2006--- The Greater Albuquerque Chamber of Commerce announced that Maas BiolAB has been chosen to receive the Innovate ABQ Award which recognizes young companies and their founders for innovative approaches to product development and business operations.   The award was presented to the ten most innovative companies in the Albuquerque area at the Chamber’s Innovate Albuquerque Entrepreneur/Small Business Awards Breakfast on February 21st at the Embassy Suites Hotel in Albuquerque.  Gerald L. Shaheen, Vice chairman of the board of directors, U.S. Chamber of Commerce and Group President, Caterpillar Inc., was the keynote speaker of the event.  
 
Maas BiolAB is a privately held neuropharmaceutical corporation based in Albuquerque, NM, USA developing the proprietary cyclosporin formulation Mitogard™ for the brain diseases of Alzheimer’s, Parkinson’s, and Huntington’s and amyotrophic lateral sclerosis (ALS). NeuroPharma AB is a Maas corporate and research partner developing NeuroSTAT™, a proprietary non-toxic intravenous cyclosporin formula to treat traumatic brain injury, spinal cord injury and stroke. NeuroPharma AB is located in the Medicon Valley biotechnology center of southern Sweden, and has research affiliation with the laboratories of the Wallenberg Neuroscience Center, Lund University.  For more information please visit www.maasbiolab.com

 
Maas BiolAB
Technology Ventures Corp. Incubator
1155 University Blvd. SE
Albuquerque, NM 87106
+1-505-843-4230 tel
+1-505-246-2891 fax